| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 28 |
| 1 | INFLIXIMAB | 21 |
| 2 | DEXAMETHASONE | 20 |
| 3 | DEXAMETHASONE 1.5 MG | 20 |
| 4 | PREDNISOLONE | 17 |
| 5 | PREDNISOLONE ORAL | 17 |
| 6 | PREDNISOLONE ORAL SOLUTION | 17 |
| 7 | AZATHIOPRINE | 15 |
| 8 | RITUXIMAB | 15 |
| 9 | CYCLOPHOSPHAMIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTAXIME INJECTION | 6 | 0.0014 |
| 1 | AMPICILLIN INJECTION | 10 | 0.0013 |
| 2 | AMPICILLIN | 10 | 0.0012 |
| 3 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 4 | MANNITOL | 3 | 0.0006 |
| 5 | GENTAMICIN SULFATE | 8 | 0.0005 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| 7 | GOLIMUMAB | 4 | 0.0003 |
| 8 | INSTALAX POLYETHYLENE GLYCOL 3350 | 4 | 0.0003 |
| 9 | POLYETHYLENE GLYCOL 400 | 4 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 70 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 15 |
| 3 | Purine Antimetabolite [EPC] | 15 |
| 4 | Alkylating Drug [EPC] | 13 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 6 | Factor Xa Inhibitor [EPC] | 9 |
| 7 | Thalidomide Analog [EPC] | 9 |
| 8 | Platinum-based Drug [EPC] | 8 |
| 9 | Topoisomerase Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 4 | Penem Antibacterial [EPC] | 6 | 0.0002 |
| 5 | Purine Antimetabolite [EPC] | 15 | 0.0002 |
| 6 | Typical Antipsychotic [EPC] | 3 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 9 | Aminoglycoside Antibacterial [EPC] | 4 | 0.0001 |